IDH2 and central nervous system cancer: The association with IDH-mutant gliomas was persistently significant, when analyzed for different WHO-grades or for different genetic subtypes (carrying mutational profiles attributed to oligodendrogliomas or astrocytomas by the 2014 Haarlem Consensus)23.